Suppr超能文献

医生对影响低风险前列腺癌男性治疗决策过程因素的认知

Physicians' Perceptions of Factors Influencing the Treatment Decision-making Process for Men With Low-risk Prostate Cancer.

作者信息

Davis Kimberly, Bellini Paula, Hagerman Charlotte, Zinar Riley, Leigh Daniel, Hoffman Richard, Aaronson David, Van Den Eeden Stephen, Philips George, Taylor Kathryn

机构信息

Department of Oncology, Georgetown University Medical Center, Lombardi Comprehensive Cancer Center, Washington, DC.

Department of Oncology, Georgetown University Medical Center, Lombardi Comprehensive Cancer Center, Washington, DC.

出版信息

Urology. 2017 Sep;107:86-95. doi: 10.1016/j.urology.2017.02.056. Epub 2017 Apr 25.

Abstract

OBJECTIVE

To assess physicians' attitudes regarding multiple factors that may influence recommendations for active surveillance (AS) vs active treatment (AT) given the central role physicians play in the treatment decision-making process.

MATERIALS AND METHODS

We conducted semistructured interviews to assess factors that physicians consider important when recommending AS vs AT, as well as physicians' perceptions of what their patients consider important in the decision. Participants included urologists (N = 11), radiation oncologists (N = 12), and primary care physicians (N = 10) from both integrated and fee-for-service healthcare settings.

RESULTS

Across the specialties, quantitative data indicated that most physicians reported that their recommendations for AS were influenced by patients' older age, willingness and ability to follow a surveillance protocol, anxiety, comorbidities, life expectancy, and treatment preferences. Qualitative findings highlighted physicians' concerns about malpractice lawsuits, given the possibility of disease progression. Additionally, most physicians noted the role of the healthcare setting, suggesting that financial incentives may be associated with AT recommendations in fee-for-service settings. Finally, most physicians reported spouse or family opposition to AS due to their own anxiety or lack of understanding of AS.

CONCLUSION

We found that patient and physician preferences, healthcare setting, and family or spouse factors influence physicians' treatment recommendations for men with low-risk PCa. These were consistent themes across physician subspecialties in both an Health Maintenance Organization and in fee-for-service settings.

摘要

目的

鉴于医生在治疗决策过程中发挥的核心作用,评估医生对可能影响主动监测(AS)与主动治疗(AT)建议的多种因素的态度。

材料与方法

我们进行了半结构化访谈,以评估医生在推荐AS与AT时认为重要的因素,以及医生对患者在决策中认为重要因素的看法。参与者包括来自综合医疗和按服务收费医疗环境的泌尿科医生(N = 11)、放射肿瘤学家(N = 12)和初级保健医生(N = 10)。

结果

在各个专业中,定量数据表明,大多数医生报告称,他们对AS的建议受到患者年龄较大、遵循监测方案的意愿和能力、焦虑、合并症、预期寿命以及治疗偏好的影响。定性研究结果突出了医生对医疗事故诉讼的担忧,因为存在疾病进展的可能性。此外,大多数医生指出了医疗环境的作用,表明在按服务收费的环境中,经济激励可能与AT建议有关。最后,大多数医生报告称,配偶或家人因自身焦虑或对AS缺乏了解而反对AS。

结论

我们发现,患者和医生的偏好、医疗环境以及家庭或配偶因素会影响医生对低风险前列腺癌男性患者的治疗建议。在健康维护组织和按服务收费的环境中,这些是各医生亚专业中一致的主题。

相似文献

1
Physicians' Perceptions of Factors Influencing the Treatment Decision-making Process for Men With Low-risk Prostate Cancer.
Urology. 2017 Sep;107:86-95. doi: 10.1016/j.urology.2017.02.056. Epub 2017 Apr 25.
5
Urologists' Current Practices in Screening and Treating Men With a Family History of Prostate Cancer.
Urology. 2017 Jan;99:180-185. doi: 10.1016/j.urology.2016.07.032. Epub 2016 Sep 16.
8
Missed expectations? Physicians' views of patients' participation in medical decision-making.
Med Care. 2005 May;43(5):466-70. doi: 10.1097/01.mlr.0000160415.08497.11.
9
Urologists' Perceptions of Active Surveillance and Their Recommendations for Low-risk Prostate Cancer Patients.
Urology. 2021 Sep;155:83-90. doi: 10.1016/j.urology.2020.12.037. Epub 2021 Jan 19.
10
Qualitative study on decision-making by prostate cancer physicians during active surveillance.
BJU Int. 2017 Jul;120(1):32-39. doi: 10.1111/bju.13651. Epub 2016 Oct 2.

引用本文的文献

1
Integrating patient values and preferences in healthcare: a systematic review of qualitative evidence.
BMJ Open. 2022 Nov 18;12(11):e067268. doi: 10.1136/bmjopen-2022-067268.
2
Multi-disciplinary and shared decision-making approach in the management of organ-confined prostate cancer.
Arab J Urol. 2018 Aug 6;16(4):367-377. doi: 10.1016/j.aju.2018.06.008. eCollection 2018 Dec.
3
Patient Factors That Influence How Physicians Discuss Active Surveillance With Low-Risk Prostate Cancer Patients: A Qualitative Study.
Am J Mens Health. 2018 Sep;12(5):1719-1727. doi: 10.1177/1557988318785741. Epub 2018 Jul 4.
4
Quality of life in active surveillance and the associations with decision-making-a literature review.
Transl Androl Urol. 2018 Feb;7(1):160-169. doi: 10.21037/tau.2017.12.34.
5
Influence of Men's Personality and Social Support on Treatment Decision-Making for Localized Prostate Cancer.
Biomed Res Int. 2017;2017:1467056. doi: 10.1155/2017/1467056. Epub 2017 Jul 12.
6
Physicians' perspectives on the informational needs of low-risk prostate cancer patients.
Health Educ Res. 2017 Apr 1;32(2):134-152. doi: 10.1093/her/cyx035.

本文引用的文献

1
Decision-making processes among men with low-risk prostate cancer: A survey study.
Psychooncology. 2018 Jan;27(1):325-332. doi: 10.1002/pon.4469. Epub 2017 Jul 13.
2
Treatment Preferences for Active Surveillance versus Active Treatment among Men with Low-Risk Prostate Cancer.
Cancer Epidemiol Biomarkers Prev. 2016 Aug;25(8):1240-50. doi: 10.1158/1055-9965.EPI-15-1079. Epub 2016 Jun 2.
3
Population-based assessment of determining predictors for quality of prostate cancer surveillance.
Cancer. 2015 Dec 1;121(23):4150-7. doi: 10.1002/cncr.29574. Epub 2015 Aug 26.
4
Informed Decision Making: Assessment of the Quality of Physician Communication about Prostate Cancer Diagnosis and Treatment.
Med Decis Making. 2015 Nov;35(8):999-1009. doi: 10.1177/0272989X15597226. Epub 2015 Aug 24.
5
Cost implications and complications of overtreatment of low-risk prostate cancer in the United States.
J Natl Compr Canc Netw. 2015 Jan;13(1):61-8. doi: 10.6004/jnccn.2015.0009.
6
Long-term follow-up of a large active surveillance cohort of patients with prostate cancer.
J Clin Oncol. 2015 Jan 20;33(3):272-7. doi: 10.1200/JCO.2014.55.1192. Epub 2014 Dec 15.
9
Long-term functional outcomes after treatment for localized prostate cancer.
N Engl J Med. 2013 Jan 31;368(5):436-45. doi: 10.1056/NEJMoa1209978.
10
A multi-institutional evaluation of active surveillance for low risk prostate cancer.
J Urol. 2013 Jan;189(1 Suppl):S19-25; discussion S25. doi: 10.1016/j.juro.2012.11.023.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验